Metabolomics and In-Silico Analysis Reveal Critical Energy Deregulations in Animal Models of Parkinson's Disease

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Poliquin, Pierre O ^a   Chen, Jingkui ^a   Cloutier, Mathieu ^b   Trudeau, Louis Éric ^c   Jolicoeur, Mario ^a  

^a ÉCOLE POLYTECHNIQUE DE MONTRÉAL   (Canada)

^b GERAD   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; NUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; BRAIN TISSUE; CELL POPULATION; COMPUTER MODEL; CONTROLLED STUDY; ENERGY DEREGULATION; ENERGY METABOLISM; GENETIC MODEL; MATHEMATICAL MODEL; METABOLITE; METABOLOMICS; MOUSE; NONHUMAN; PARKINSON DISEASE; QUANTITATIVE ANALYSIS; SIMULATION; STRESS;

ANIMALS; BRAIN; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; COMPUTER SIMULATION; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; METABOLOMICS; MICE; MICE, KNOCKOUT; PARKINSON DISEASE; STRESS, PHYSIOLOGICAL; UBIQUITIN-PROTEIN LIGASES;

EID: 84880708061     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069146     Document Type: Article

References (40)

1. Goedert M, (2001) Alpha-synuclein and neurodegenerative diseases. Nature Reviews Neuroscience 2: 492-501.
2. Uversky VN, (2007) Neuropathology, biochemistry, and biophysics of α-synuclein aggregation. Journal of Neurochemistry 103: 17-37.
3. Rinne J, Rummukainen J, Paljarvi L, Rinne U, (1989) Dementia in Parkinson's disease is related to neuronal loss in themedial substantia nigra. Annals of Neurology 26: 47-50.
4. Bergareche A, Puente E, López de Munain A, Sarasqueta C, Arce A, et al. (2004) Prevalence of Parkinson's disease and other types of Parkinsonism. Journal of Neurology 251: 340-345.
5. Halbach OvBu, Schober A, Krieglstein K, (2004) Genes, proteins, and neurotoxins involved in Parkinson's disease. Progress in Neurobiology 73: 151-177.
6. Viartis (2009) Parkinson's Disease. London, England.
7. Langston JW, Ballard P, Tetrud J, Irwin I, (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219: 979-980.
8. Fermaglich J, (1996) The Case of the Frozen Addicts. The Journal of the American Medical Association 275: 407-408.
9. Miller GW, (2007) Paraquat: The Red Herring of Parkinson's Disease Research. Toxicological Sciences 100: 1-2.
10. NLoM NLoM (2011) Genetics Home Reference. pp. Genetics Home Reference provides consumer-friendly information about the effects of genetic variations on human health.
11. Dawson TM, Dawson VL, (2003) Molecular Pathways of Neurodegeneration in Parkinson's Disease. Science 302: 819-822.
12. Fahn S, Sulzer D, (2004) Neurodegeneration and Neuroprotection in Parkinson Disease. The American Society for Experimental NeuroTherapeutics 1: 139-154.
13. Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C, (2010) Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Human Mutation 31: 763-780.
14. Beal MF, (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Annals of neurology 38: 357-366.
15. Matsumine H, Saito M, Shimoda-Matsubayashi S, Tanaka H, Ishikawa A, et al. (1997) Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27. The American Journal of Human Genetics 60: 588-596.
16. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, et al. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392: 605-608.
17. Itier J-M, Ibáñez P, Mena MA, Abbas N, Cohen-Salmon C, et al. (2003) Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Human Molecular Genetics 12: 2277-2291.
18. Vives-Bauza C, Zhou C, Huang Y, Cui M, de Vries RLA, et al. (2009) PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proceedings of the National Academy of Sciences 107: 378-383.
19. Weber J, Senior AE, (2003) ATP synthesis driven by proton transport in F1F0-ATP synthase. FEBS Letters 545: 61-70.
20. Cloutier M, Wellstead P, (2010) The control systems structures of energy metabolism. Journal of the Royal Society Interface 7: 651-665.
21. Wellstead P, Cloutier M, (2010) An energy systems approach to Parkinson's disease. Wiley Interdisciplinary Reviews: Systems Biology and Medicine 3: 1-6.
22. Tyson JJ, Chen KC, Novak B, (2003) Sniffers, buzzers, toggles and blinkers: dynamics of regulatory and signaling pathways in the cell. Current Opinion in Cell Biology 15: 221-231.
23. Haefner JW (1996) Modeling biological systems: principles and applications. New York [u.a.]: Capman & Hall [u.a.].
24. Luo B, Groenke K, Takors R, Wandrey C, Oldiges M, (2007) Simultaneous determination of multiple intracellular metabolites in glycolysis, pentose phosphate pathway and tricarboxylic acid cycle by liquid chromatography-mass spectrometry. J Chromatogr A 1147: 153-164.
25. Ritter JB, Genzel Y, Reichl U, (2008) Simultaneous extraction of several metabolites of energy metabolism and related substances in mammalian cells: Optimization using experimental design. Anal Biochem 373: 349-369.
26. Faijes M, Mars AE, Smid EJ, (2007) Comparision of quenching and extraction methodologies for metabolome analysis of Lactobacillus plantarum. Microbial Cell Factories 6: 1-8.
27. Hammami I, Chen J, Bronte V, DeCrescenzo G, Jolicoeur M, (2012) l-glutamine is a key parameter in the immunosuppression phenomenon. Biochemical and Biophysical Research Communications 425: 724-729.
28. Cloutier M, Bolger F, Lowry J, Wellstead P (2009) An integrative dynamic model of brain energy metabolism using in vivo neurochemical measurements. Journal of Computational Neuroscience. Maynooth, Co. Kildare, Ireland: Springer Netherlands. 24.
29. Ghorbaniaghdam Henry, (2013) Jolicoeur (2013) A kinetic-metabolic model based on cell energetic state: Study of CHO cells behaviour under Na-butyrate stimulation. Bioprocess and Biosystems Engineering Journal. 36: 469-487.
30. Schmidt H, Jirstrand M, (2006) Systems Biology Toolbox for MATLAB: A computational platform for research in Systems Biology. Bioinformatics 22: 514-515.
31. Sneppen K, Lizana L, Jensen MH, Pigolotti S, Otzen D, (2009) Modeling proteasome dynamics in Parkinson's disease. Physical Biology 6: 036005.
32. Qi Z, Miller GW, Voit EO, (2009) Computational analysis of determinants of dopamine (DA) dysfunction in DA nerve terminals. Synapse 63: 1133-1142.
33. Vali S, Mythri RB, Jagatha B, Padiadpu J, Ramanujan KS, et al. (2007) Integrating glutathione metabolism and mitochondrial dysfunction with implications for Parkinson's disease: A dynamic model. Neuroscience 149: 917-930.
34. Caspi R, Altman T, Dale J, Dreher K, Fulcher C, et al. (2010) The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases. Nucleic Acids Research. D473-479.
35. Scheer M, Grote A, Chang A, Schomburg I, Munaretto C, et al. (2011) BRENDA, the enzyme information system (Database issue). Nucleic Acids Res. D670-676.
36. Heinrich R, Schuster S (1996) The Regulation of Cellular Systems: Springer.
37. Cloutier M, Wellstead P, (2012) Dynamic modelling of protein and oxidative metabolisms simulates the pathogenesis of Parkinson's disease. IET Systems Biology 6: 65-72.
38. Owen JB, Butterfield DA, (2010) Measurement of Oxidized/Reduced Glutathione Ratio. Methods in Molecular Biology 648: 267-277.
39. Cloutier M, Middleton R, Wellstead P, (2012) A feedback motif for the pathogenesis of Parkinson's disease. The Institution of Engineering and Technology, Systems Biology 6: 86-93.
40. Langston JW, Palfreman J (1995) The case of the frozen addicts. New York: Pantheon Books.